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Background: Endoscopic resection has become the standard treatment for noninvasive gastro-
intestinal malignancies. In flat mucosal tumors, normal saline is frequently used for submucosal 
fluid injection in order to reduce the risk of complications during endoscopic resection. Recent 
studies have demonstrated longer-lasting mucosa elevation by injection of agents such as 
hyaluronic acid or glyceol, rather than normal saline. We investigated the efficacy of different 
blood components in comparison with other solutions for use as a submucosal fluid cushion.
Methods: Normal saline, sodium hyaluronate, glyceol, hydroxyethyl starch, serum, plasma, 
and whole blood were evaluated for their effectiveness in creating a submucosal cushion. One 
  milliliter of each solution was injected into the submucosa of 5 × 5 cm specimens of resected 
porcine stomach. Mucosa elevation was measured before and up to 60 minutes after injection.
Results: The shortest duration of mucosa elevation was observed after injection of normal 
saline, glyceol, and 0.125% hyaluronic acid. A significantly longer duration was obtained after 
injection of hydroxyethyl starch, 0.25% and 0.5% hyaluronic acid, serum, and plasma. However, 
whole blood generated a longer-lasting mucosa elevation than all other agents.
Conclusion: The results of the current study suggest that whole blood is more effective in 
generating long-lasting mucosa elevation than any other commonly used solution. Because 
autologous blood is readily available at almost no cost, this seems to be an optimal agent for 
creating the mucosa elevation needed for endoscopic resection. Further in vivo studies in humans 
are needed to clarify the potential role of autologous blood for long-lasting endoscopic mucosa 
resection or endoscopic submucosal dissection.
Keywords: submucosal injection, blood components, sodium hyaluronate, glycerol, normal 
saline, endoscopic mucosal resection
Introduction
Endoscopic resection modalities such as endoscopic mucosa resection (EMR) or 
endoscopic submucosal dissection (ESD) are now established as the standard treat-
ment modality in the treatment of noninvasive mucosal tumors along the gastroin-
testinal tract.1–5 Especially in flat or nonpedunculated lesions, submucosal injection 
of normal saline (NS) solution is widely used for separating the lesion from the 
muscularis propria to allow its resection and prevent perforation and thermal injury 
to the intestinal wall.6–9 However, mucosa elevation is usually seen for only a short 
period after NS injection, so repeated injections are required. In recent years, several 
solutions, such as sodium hyaluronate, hydroxypropyl methylcellulose, mannitol, 
glyceol (G), and fibrinogen, have been investigated and have been shown to extend 
the duration of mucosal elevation.10–14 However, disadvantages such as high costs and 
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difficult administration, as well as concerns about stimula-
tion of tumor cells, have obviated the use of these solutions 
in routine endoscopy.
The aim of this study was to compare the effectiveness 
of different components of blood with NS, hyaluronic acid 
(HA), G, and hydroxyethyl starch (HES) on mucosa elevation 
after submucosal injection.
Materials and methods
NS (B Braun Melsungen AG, Melsungen, Germany), 0.125% 
HA, 0.25% HA, 0.5% HA (Suvenyl®, Chugai Pharmaceutical 
Co, Tokyo, Japan), G (10% glycerin with 0.9% NaCl plus 
5% fructose; Chugai Pharmaceutical Co, Tokyo, Japan), and 
HES 6% (Fresenius Kabi AG, Bad Homburg, Germany), 
as well as whole blood, plasma, and serum (collected from 
the corresponding author) were used in this study to create 
a submucosal fluid cushion. Squares of resected porcine 
stomach (5 × 5 cm) were stretched on a corkboard. To ensure 
a constant distance and angle of the specimens relative to a 
camera, a special construction with fixed camera position and 
fixed specimen position was used (Figure 1). One milliliter 
of one of the solutions was horizontally injected into the 
submucosa from the margin of the specimen using a 1 mL 
syringe with a 23-gauge needle.
Digital pictures were taken before injection, immediately 
after injection, and every 5 minutes thereafter for up to 
60 minutes – this was controlled by Nikon Camera Control 
Pro Software (v 1.3.0; Nikon Inc, Melville, NY). Pictures 
were taken using a Nikon D70S camera with a Nikkor DF 
Micro 60 mm zoom lens (Nikon Inc). Each experiment was 
independently repeated five times. The recorded pictures 
(Figure 2) were analyzed in a blinded fashion using Adobe 
Photoshop (v CS3; Adobe Systems Inc, San Jose, CA), which 
allowed measurement of mucosa height before and after 
submucosal fluid injection.
Statistical analysis was performed with a Student’s t-test 
using GraphPad Prism (v 5.01; GraphPad Software Inc, La 
Jolla, CA).
Results
Average mucosa elevation immediately after submucosal 
injection was between 5.9 and 7.1 mm (Figure 3). Submucosa 
injected with whole blood resulted in a slight but significantly 
higher mucosa elevation compared with G. However, average 
mucosa elevation did not differ significantly among the other 
solutions used in this study (Figure 3).
Over time, a decrease of mucosa elevation was observed 
for all agents used. Significant differences in the duration of 
Figure 1 Test arrangement with fixed position of camera and cork plate.
elevation could be observed and three distinct groups became 
evident in terms of the rate of decrease and final height 
plateau. NS, G, and 0.125% sodium hyaluronate showed 
the fastest decrease of average mucosa elevation during the 
observation period, as well as the lowest level of average 
mucosa elevation after 60 minutes (3.38–3.55 mm), with 
no significant difference observed between these solutions. 
In contrast, serum and plasma produced a significantly slower 
decrease of average mucosa elevation and a significantly 
higher final plateau (3.95–4.35 mm), which was comparable 
to HES, 0.25% HA, and 0.5% HA. The slowest decrease 
of average mucosa elevation and the highest final height 
plateau (5.23 mm) was observed by using whole blood 
(Figures 4 and 5).
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Figure 2 Representative example of overlaid pictures of the gastric wall before, immediately, 5 minutes, and 60 minutes after submucosal fluid injection.
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Figure 3 Absolute mucosa elevation immediately after injection of 1 mL solution (average height and standard deviation). 
Note: *P , 0.05. 
Abbreviations: nS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.
Discussion
Creating a submucosal cushion is a standard method during 
endoscopic resection of flat or nonpedunculated lesions in 
the gastrointestinal tract as this reduces the risk of perforation 
and thermal injury to the gastrointestinal wall. Particularly 
for the submucosal dissection technique, mucosa elevation 
by submucosal fluid injection is considered very important 
for reducing the risk of perforation. Mucosa elevation is most 
commonly achieved by injecting NS into the submucosa, 
but the mucosa elevation this generates often decreases 
quite rapidly due to diffusion into the surrounding tissue. 
Therefore, different solutions, such as   hyperosmolaric 
  dextrose solutions, hydroxypropyl methylcellulose, 
G,   mannitol, and HA, have been extensively investigated for 
their ability to lengthen the duration of elevation.10–12,14–17
Most notably, HA has been shown to create longer-
lasting fluid cushions compared with NS both ex vivo and 
in vivo. However, HA has disadvantages – namely, its high 
cost and the conflicting data concerning stimulation of 
tumor growth, which currently inhibit its general use for 
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Figure 4 Average absolute mucosa elevation over time after injection of 1 mL solution. 
Notes: *P , 0.01; **P , 0.0001. 
Abbreviations: nS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.
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Figure 5 Average relative reduction of mucosa elevation over time after injection of 1 mL solution. 
Abbreviations: nS, normal saline; G, glyceol; HA, hyaluronic acid; HES, hydroxyethyl starch; S, serum; P, plasma; WB, whole blood.
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submucosal injection.18,19 Hyperosmolaric solutions are 
implicated in increasing tissue damage and delaying heal-
ing of resection ulcers as well as reducing the quality of 
resected specimens.20 Research has demonstrated a correla-
tion between the duration of mucosal elevation and viscos-
ity, but not osmolarity.14 Other agents such as fibrinogen 
mixtures13,14,21 and poloxamers22 can also be used for creat-
ing a more durable mucosa elevation.   Compared with HA, 
fibrinogen mixtures and poloxamer solutions are significantly 
less expensive but remain substantially more expensive than 
NS. In addition, the use of fibrinogen mixtures for endoscopic 
resections still needs to be critically considered with regard 
to their potential to transfer infections.
The present research has demonstrated that duration of 
mucosa elevation was significantly lengthened by the use 
of HA at concentrations of 0.5% and 0.25%, as compared 
with NS, a finding that agrees with other studies. However, 
the effect of 0.125% HA solutions on mucosa elevation was 
similar to NS. G, a hypertonic solution consisting of 10% 
glycerin with 0.9% NS plus 5% fructose, has been discussed 
as an alternative to HA.15 In the current study, the effect of G 
on mucosal elevation was inferior to HA, to the extent that 
no difference was observed between G and NS. A   previous 
study also demonstrated the inferiority of G compared 
with 0.5% and 0.25% HA, but G did show longer-lasting 
elevation than NS.12 In addition, the potential role of HES 
was investigated and no difference was observed relative to 
0.5% and 0.25% HA, serum, or plasma, which is consistent 
with the results of another recent study.23 However, there is 
some suggestion that HES solutions may exert adverse effects 
on plasmatic coagulation and platelet function, so these may 
promote bleeding during or after endoscopic resection.24
The results of the current study suggest that autologous 
blood and its components may serve as cheap alternatives for 
achieving a longer-lasting mucosa elevation without risk of 
transmission of infection. Serum and plasma seem to be as 
effective as 0.25% and 0.5% HA. However, a problem with the 
use of plasma or serum in routine endoscopy may be difficulty 
in rapidly preparing the patient’s blood immediately prior to 
the endoscopic procedure, particularly because this would 
often need to be performed within the endoscopy unit.
Injection of whole blood gave superior height and 
duration of submucosa elevation compared with all other 
solutions tested. Therefore, autologous whole blood might 
serve as an optimal agent for ESD or EMR procedures that 
require long-lasting submucosa elevation. However, several 
questions have to be answered before whole blood is rou-
tinely used as a submucosal cushion fluid, as submucosal 
injection of autologous blood could hamper the specialist’s 
view during the endoscopic resection procedure. Moreover, 
electrocauterization during endoscopic resection could 
impair the specialist’s vision by introducing burning arti-
facts. However, dark dyes like methylene blue or toluidine 
blue are regularly used for submucosal injection without 
impairing vision during endoscopic resection and a recent 
study did not observe any impairment of visualization or 
other technical problems after the submucosal injection of 
autologous blood prior to endoscopic resection in a porcine 
model. Furthermore, injection of autologous blood seemed 
to promote local hemostasis and the clot of the fresh injected 
blood that formed facilitated the endoscopic resection by 
separating the muscularis from the submucosal layer of the 
gastric wall.25
Another disadvantage of using whole blood as a cushion 
fluid might be blood coagulation. Further studies are required 
to investigate whether this can be resolved by taking the blood 
sample immediately before submucosal injection.
Autologous blood is readily available at low cost so may 
represent an optimal agent for creating the mucosa elevation 
needed for endoscopic resection. Further in vivo studies in 
humans are needed to clarify the potential role of autologous 
blood for long-lasting EMR or ESD.
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